Skip to main content

Missing Data

  • Chapter
  • First Online:
Biopharmaceutical Applied Statistics Symposium

Part of the book series: ICSA Book Series in Statistics ((ICSABSS))

  • 650 Accesses

Abstract

Missing data in clinical trials are defined as planned information that was not collected. Examples of these include a subject withdrawing consent before the end of a trial or a laboratory test that cannot be obtained. Depending on why and how much data are missing, the results and interpretability of the trial can be jeopardized. Fortunately, there is a vast literature about statistical methods that can handle missing data. Probably the most important—and least technical—point in this literature is to do everything possible beginning at the trial design stage to avoid missing data. Even when the trial is designed to minimize missing data, the analysis plan should address how the analysis will proceed in the presence of missing data. This chapter should be viewed as a springboard into understanding the minimal amount of theory to apply these methods and begin reading the source literature.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 119.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Notes

  1. 1.

    The model can be extended further by allowing R to take on more than two values indicating multiple response patterns. This will be necessary for applying pattern mixture models.

  2. 2.

    Common notation for the Var(e) is R but has been changed to P to avoid confusion with the response vector R.

References

  • Cao, W., Tsiatis, A. A., & Davidian, M. (2009). Improving efficiency and robustness of the doubly robust estimator for a population mean with incomplete data. Biometrika (Oxford Academic).

    Google Scholar 

  • Carpenter, J., & Kenward, M. (2012). Multiple imputation and its application. Statistics in Practice. Wiley.

    Google Scholar 

  • Collins, L. M., Schafer, J. L., & Kam, C.-M. (2001). A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychological Methods, 6(4), 330–351.

    Google Scholar 

  • Fairclough, D. L. (2010). Design and analysis of quality of life studies in clinical trials, 2nd ed. Chapman and Hall/CRC.

    Google Scholar 

  • Ibrahim, J.G., & Molenberghs, G. (2009). Missing data methods in longitudinal studies: A review. Test, 18(1), 1–43.

    Google Scholar 

  • Kang, J. D. Y., & Schafer, L. J. (2007). Demystifying double robustness: A comparison of alternative strategies for estimating a population mean from incomplete data. Statistical Science, 22(4), 523–539.

    Google Scholar 

  • Mallinckrodt, C. H., Scott Clark, W., & David, S. R. (2001). Type i error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward. Drug Information Journal, 35(4), 1215–1225. https://doi.org/10.1177/009286150103500418

  • Mallinckrodt, C. H., Lin, Q., Lipkovich, I., & Molenberghs, G. (2012). A structured approach to choosing estimands and estimators in longitudinal clinical trials. Pharmaceutical Statistics, 11(6), 456–461.

    Article  Google Scholar 

  • Molenberghs, G., & Verbeke, G. (2005). Models for discrete longitudinal data. Springer.

    Google Scholar 

  • National Research Council (2010). The Prevention and Treatment of Missing Data in Clinical Trials.

    Google Scholar 

  • O’Neill, R. T., & Temple, R. (2012). The prevention and treatment of missing data in clinical trials: An FDA perspective on the importance of dealing with it. Clinical Pharmacology and Therapeutics, 91(3), 550–554.

    Article  Google Scholar 

  • Rubin, D. B. (1996). Multiple imputation after 18 years. Journal of the American Statistical Association, 91(434), 473.

    Google Scholar 

  • SAS/STAT 14.1 user’s guide, Carey, NC (2015).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven A. Gilbert .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gilbert, S.A., Christensen, J.C. (2018). Missing Data. In: Peace, K., Chen, DG., Menon, S. (eds) Biopharmaceutical Applied Statistics Symposium . ICSA Book Series in Statistics. Springer, Singapore. https://doi.org/10.1007/978-981-10-7826-2_9

Download citation

Publish with us

Policies and ethics